| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Glaucoma | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hypertension | |||||
| Ocular Hypertension | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Eye Diseases | |||||
| Vascular Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Dorzolamide | |||||
| Timolol | |||||
| 5 | More general drug interventions related to this trial | ||||
| Adrenergic Agents | |||||
| Adrenergic Antagonists | |||||
| Adrenergic beta-Antagonists | |||||
| Anti-Arrhythmia Agents | |||||
| Antihypertensive Agents | |||||
| Carbonic Anhydrase Inhibitors | |||||
| Cardiovascular Agents | |||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| Merck | |||||
|
